GL1X · GenesisL1 explorer

MolNFT v1 · #8881 · protein

Human biliverdin IX beta reductase: NADP/BILIVERDIN IX alpha ternary complex

1HE2: “Human biliverdin IX beta reductase: NADP/BILIVERDIN IX alpha ternary complex”. X-ray diffraction, 2 ligands (NAP, BLA), 1 pocket (best druggability 0.72). MolNFT v1 #8881 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1HE2
Type
protein
Length
205 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Biliverdin IX beta reductase
EC
1.3.1.24
UniProt
P30043
Ligands
NAP, BLA
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABiliverdin IX beta reductase (EC 1.3.1.24)protein20538% helix, 21% strandP30043

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • BLA · Biliverdine IX alpha · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15050.720.8144NAP, BLA

Compared structures

  • 1HE2 · Human biliverdin IX beta reductase: NADP/biliverdin IX alpha ternary complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P30043 · AlphaFold monomer V2.0 prediction for flavin reductase (NADPH) (P30043) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.